AAAAAA

   
Results: 1-25 | 26-29
Results: 1-25/29
IL-2 EXPANSION OF T-CELL AND NK-CELL FROM GROWTH FACTOR-MOBILIZED PERIPHERAL-BLOOD STEM-CELL PRODUCTS - MONOCYTE INHIBITION
Authors: AGEITOS AG SINGH RK INO K OZEROL I TARANTOLO S REED EK TALMADGE JE
Citation: Ag. Ageitos et al., IL-2 EXPANSION OF T-CELL AND NK-CELL FROM GROWTH FACTOR-MOBILIZED PERIPHERAL-BLOOD STEM-CELL PRODUCTS - MONOCYTE INHIBITION, Journal of immunotherapy, 21(6), 1998, pp. 409-417
CENTRAL VENOUS CATHETER-RELATED CORYNEBACTERIUM-MINUTISSIMUM BACTEREMIA
Authors: RUPP ME STILES KG TARANTOLO S GOERING RV
Citation: Me. Rupp et al., CENTRAL VENOUS CATHETER-RELATED CORYNEBACTERIUM-MINUTISSIMUM BACTEREMIA, Infection control and hospital epidemiology, 19(10), 1998, pp. 786-789
PERIPHERAL TOLERANCE INDUCED VIA FASL-MEDIATED MONOCYTE-DEPENDENT CD4(-CANCER PATIENTS FOLLOWING STEM-CELL TRANSPLANTATION() CELLS APOPTOSIS IN BREAST)
Authors: TALMADGE JE SINGH RK VARNEY ML BUYUKBERBER S INO K AGEITOS AG REED E TARANTOLO S
Citation: Je. Talmadge et al., PERIPHERAL TOLERANCE INDUCED VIA FASL-MEDIATED MONOCYTE-DEPENDENT CD4(-CANCER PATIENTS FOLLOWING STEM-CELL TRANSPLANTATION() CELLS APOPTOSIS IN BREAST), The FASEB journal, 12(4), 1998, pp. 3397-3397
PERIPHERAL-BLOOD PROGENITOR CELLS - ENABLING OUTPATIENT TRANSPLANTATION
Authors: MCGUIRE TR TARANTOLO S REED E
Citation: Tr. Mcguire et al., PERIPHERAL-BLOOD PROGENITOR CELLS - ENABLING OUTPATIENT TRANSPLANTATION, Pharmacotherapy, 18(1), 1998, pp. 17-23
THERAPY WITH IV BUSULFAN, CYTOXAN (BUCY) AND ALLOGENEIC HEMATOPOIETICSTEM-CELLS (HSC) FOR ADVANCED HEMATOLOGICAL MALIGNANCIES
Authors: ANDERSSON BS MARTINKA S MCWILLIAMS K HAI T MOLLDREM J BRUTON J GIAN V FERNANDEZ H TARANTOLO S KASHYAP A FORMAN SJ HU W BLUME K CAGNONI P JONES R CHAMPLIN RE
Citation: Bs. Andersson et al., THERAPY WITH IV BUSULFAN, CYTOXAN (BUCY) AND ALLOGENEIC HEMATOPOIETICSTEM-CELLS (HSC) FOR ADVANCED HEMATOLOGICAL MALIGNANCIES, Bone marrow transplantation, 21, 1998, pp. 333-333
DISSEMINATED ASPERGILLOSIS CAUSED BY ASPERGILLUS-USTUS IN A PATIENT FOLLOWING ALLOGENEIC PERIPHERAL STEM-CELL TRANSPLANTATION
Authors: IWEN PC RUPP ME BISHOP MR RINALDI MG SUTTON DA TARANTOLO S HINRICHS SH
Citation: Pc. Iwen et al., DISSEMINATED ASPERGILLOSIS CAUSED BY ASPERGILLUS-USTUS IN A PATIENT FOLLOWING ALLOGENEIC PERIPHERAL STEM-CELL TRANSPLANTATION, Journal of clinical microbiology (Print), 36(12), 1998, pp. 3713-3717
NORMAL SALINE VERSUS HEPARIN FLUSH FOR MAINTAINING CENTRAL VENOUS CATHETER PATENCY DURING APHERESIS COLLECTION OF PERIPHERAL-BLOOD STEM-CELLS (PBSC)
Authors: STEPHENS LC HAIRE WD TARANTOLO S REED E SCHMITPOKORNY K KESSINGER A KLEIN R
Citation: Lc. Stephens et al., NORMAL SALINE VERSUS HEPARIN FLUSH FOR MAINTAINING CENTRAL VENOUS CATHETER PATENCY DURING APHERESIS COLLECTION OF PERIPHERAL-BLOOD STEM-CELLS (PBSC), Transfusion science, 18(2), 1997, pp. 187-193
RESTORATION OF T-CELL-FUNCTION AND NK-CELL-FUNCTION IN GM-CSF MOBILIZED STEM-CELL PRODUCTS FROM BREAST-CANCER PATIENTS BY MONOCYTE DEPLETION
Authors: AGEITOS AG INO K OZEROL I TARANTOLO S HEIMANN DG TALMADGE JE
Citation: Ag. Ageitos et al., RESTORATION OF T-CELL-FUNCTION AND NK-CELL-FUNCTION IN GM-CSF MOBILIZED STEM-CELL PRODUCTS FROM BREAST-CANCER PATIENTS BY MONOCYTE DEPLETION, Bone marrow transplantation, 20(2), 1997, pp. 117-123
CLINICOPATHOLOGICAL CHARACTERISTICS OF 32 PATIENTS WITH POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDERS
Authors: HAUKE R GREINER T SMIR B TARANTOLO S GROSS T ANDERSON J SHAW B BIERMAN P
Citation: R. Hauke et al., CLINICOPATHOLOGICAL CHARACTERISTICS OF 32 PATIENTS WITH POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDERS, Blood, 90(10), 1997, pp. 3900-3900
INCREASED PLATELET (PLT) TRANSFUSION (TX) REQUIREMENT IS ASSOCIATED WITH MULTIPLE ORGAN DYSFUNCTIONS (DFXN) IN HEMATOPOIETIC STEM-CELL TRANSPLANTATION (HSCT) PATIENTS
Authors: GORDON B TARANTOLO S RUBY E STEPHENS L KESSINGER A HAIRE W
Citation: B. Gordon et al., INCREASED PLATELET (PLT) TRANSFUSION (TX) REQUIREMENT IS ASSOCIATED WITH MULTIPLE ORGAN DYSFUNCTIONS (DFXN) IN HEMATOPOIETIC STEM-CELL TRANSPLANTATION (HSCT) PATIENTS, Blood, 90(10), 1997, pp. 971-971
ALLOGENEIC TRANSPLANTATION IN ADVANCED HEMATOLOGIC MALIGNANCIES AFTER-IV BUSULFAN CYCLOFOSFAMIDE (BUCY)
Authors: ANDERSSON BS HAI T MADDEN T CAGNONI P JONES R BRUTON J MARTINKA S HOLBERT K GIRALT S PRZEPIORKA D LENNON S SPILKER B GIAN V WINGARD J TARANTOLO S KASHYAP A FORMAN S CHAMPLIN RE
Citation: Bs. Andersson et al., ALLOGENEIC TRANSPLANTATION IN ADVANCED HEMATOLOGIC MALIGNANCIES AFTER-IV BUSULFAN CYCLOFOSFAMIDE (BUCY), Blood, 90(10), 1997, pp. 1003-1003
OUTCOMES OF PATIENTS WITH BONE-MARROW METASTASES TREATED WITH HIGH-DOSE THERAPY AND RESCUED WITH PERIPHERAL-BLOOD PROGENITOR CELLS
Authors: KESSINGER A ANDERSON J BIERMAN P BISHOP M REED E TARANTOLO S VOSE J ARMITAGE J
Citation: A. Kessinger et al., OUTCOMES OF PATIENTS WITH BONE-MARROW METASTASES TREATED WITH HIGH-DOSE THERAPY AND RESCUED WITH PERIPHERAL-BLOOD PROGENITOR CELLS, Blood, 90(10), 1997, pp. 1022-1022
MYELOMA CELL TUMOR REDUCTION IN PBPC AUTOGRAFTS FOLLOWING CD34 SELECTION - THE RESULTS OF A PHASE-III TRIAL USING THE CEPRATE DEVICE
Authors: VESCIO R STEWART A BALLESTER O NOGA S RUGO H FREYTES C STADTMAUER E KOGUT N TARANTOLO S STIFF P PINERO L DALTON W HO A SCHILLER G BENYUNES M JACOBS C DIPERSIO J ANDERSON K BERENSON J
Citation: R. Vescio et al., MYELOMA CELL TUMOR REDUCTION IN PBPC AUTOGRAFTS FOLLOWING CD34 SELECTION - THE RESULTS OF A PHASE-III TRIAL USING THE CEPRATE DEVICE, Blood, 90(10), 1997, pp. 1872-1872
INCREASE IN CIRCULATING TUMOR-CELL BURDEN DURING MOBILIZATION CHEMOTHERAPY PREDICTS FOR RELAPSE AFTER AUTOLOGOUS TRANSPLANTATION IN MULTIPLE-MYELOMA PATIENTS
Authors: VESCIO R STEWART A BALLESTER O NOGA S RUGO H FREYTES C STADTMAUER E KOGUT N TARANTOLO S STIFF P PINERO L DALTON W HO A SCHILLER G BENYUNES M JACOBS C DIPERSIO J ANDERSON K BERENSON J
Citation: R. Vescio et al., INCREASE IN CIRCULATING TUMOR-CELL BURDEN DURING MOBILIZATION CHEMOTHERAPY PREDICTS FOR RELAPSE AFTER AUTOLOGOUS TRANSPLANTATION IN MULTIPLE-MYELOMA PATIENTS, Blood, 90(10), 1997, pp. 2515-2515
THE DETECTION OF KSHV IS INCREASED BY MOBILIZATION CHEMOTHERAPY AND REDUCED IN AUTOGRAFTS BY CD34-SELECTION
Authors: VESCIO R WU C RETTIG M STEWART A BALLESTER O NOGA S RUGO H FREYTES C STADTMAUER E KOGUT N TARANTOLO S STIFF P PINERO L DALTON W HO A SCHILLER G BENYUNES M JACOBS C DIPERSIO J ANDERSON K BERENSON J
Citation: R. Vescio et al., THE DETECTION OF KSHV IS INCREASED BY MOBILIZATION CHEMOTHERAPY AND REDUCED IN AUTOGRAFTS BY CD34-SELECTION, Blood, 90(10), 1997, pp. 2516-2516
ADMINISTRATION OF GM-CSF TO BREAST-CANCER PATIENTS MOBILIZES LOW NUMBERS OF TUMOR-CELLS INTO LEUKAPHERESIS HARVESTS
Authors: TARANTOLO S TRAYSTMAN M REED EC MURPHY S MANN S KESSINGER A SHARP JG
Citation: S. Tarantolo et al., ADMINISTRATION OF GM-CSF TO BREAST-CANCER PATIENTS MOBILIZES LOW NUMBERS OF TUMOR-CELLS INTO LEUKAPHERESIS HARVESTS, Experimental hematology, 24(9), 1996, pp. 132-132
USE OF CONTINUOUS-INFUSION GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR ALONE OR FOLLOWED BY GRANULOCYTE-COLONY-STIMULATING FACTOR ENHANCE ENGRAFTMENT FOLLOWING HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR LYMPHOID MALIGNANCIES
Authors: VOSE JM BIERMAN PJ RUBY E REED EC BISHOP MR TARANTOLO S KESSINGER A ARMITAGE JO
Citation: Jm. Vose et al., USE OF CONTINUOUS-INFUSION GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR ALONE OR FOLLOWED BY GRANULOCYTE-COLONY-STIMULATING FACTOR ENHANCE ENGRAFTMENT FOLLOWING HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR LYMPHOID MALIGNANCIES, Bone marrow transplantation, 17(6), 1996, pp. 951-956
MONOCYTES FROM GROWTH-FACTOR MOBILIZED PERIPHERIAL STEM-CELL PRODUCTSINHIBIT IL-2 DRIVEN EX-VIVO EXPANSION AND FUNCTION OF T-CELL AND NK-CELL - RESTORATION FOLLOWING REMOVAL
Authors: AGEITOS AG INO K OZEROL I TARANTOLO S TALMADGE JE
Citation: Ag. Ageitos et al., MONOCYTES FROM GROWTH-FACTOR MOBILIZED PERIPHERIAL STEM-CELL PRODUCTSINHIBIT IL-2 DRIVEN EX-VIVO EXPANSION AND FUNCTION OF T-CELL AND NK-CELL - RESTORATION FOLLOWING REMOVAL, Blood, 88(10), 1996, pp. 3792-3792
HEMATOPOIETIC GROWTH-FACTORS AFTER HLA-IDENTICAL ALLOGENEIC BONE-MARROW TRANSPLANTATION IN PATIENTS TREATED WITH METHOTREXATE-CONTAINING GRAFT-VS.-HOST DISEASE PROPHYLAXIS
Authors: MARTINALGARRA S BISHOP MR TARANTOLO S COWLES MK REED E ANDERSON JR VOSE JM BIERMAN P ARMITAGE JO KESSINGER A
Citation: S. Martinalgarra et al., HEMATOPOIETIC GROWTH-FACTORS AFTER HLA-IDENTICAL ALLOGENEIC BONE-MARROW TRANSPLANTATION IN PATIENTS TREATED WITH METHOTREXATE-CONTAINING GRAFT-VS.-HOST DISEASE PROPHYLAXIS, Experimental hematology, 23(14), 1995, pp. 1503-1508
IMMUNOLOGICAL RECOVERY FOLLOWING ALLOGENEIC TRANSPLANTATION WITH PERIPHERAL-BLOOD STEM-CELLS
Authors: PAVLETIC ZS BISHOP MR TARANTOLO S NASRATI K PIRUCELLO SJ ZHANG G BIERMAN PJ REED EC VOSE JM ARMITAGE JO ANDERSON JR JOSHI SS KESSINGER A
Citation: Zs. Pavletic et al., IMMUNOLOGICAL RECOVERY FOLLOWING ALLOGENEIC TRANSPLANTATION WITH PERIPHERAL-BLOOD STEM-CELLS, Blood, 86(10), 1995, pp. 403-403
PHASE-II STUDY OF PIXY321 IN ELDERLY PATIENTS (PTS) WITH NEWLY-DIAGNOSED ACUTE MYELOCYTIC-LEUKEMIA (AML)
Authors: GELLER RB TARANTOLO S POWELL BL KALAYCIOGLU M ZAKNOEN S KLEIN L GARRISON L
Citation: Rb. Geller et al., PHASE-II STUDY OF PIXY321 IN ELDERLY PATIENTS (PTS) WITH NEWLY-DIAGNOSED ACUTE MYELOCYTIC-LEUKEMIA (AML), Blood, 86(10), 1995, pp. 3026-3026
PROCESSING AND CRYOPRESERVATION OF PERIPHERAL-BLOOD STEM-CELLS COLLECTED FROM NORMAL DONORS FOR ALLOGENEIC TRANSPLANTATION
Authors: LETHEBY BA JACKSON JD BISHOP MR KESSINGER A PIRRUCCELLO S TARANTOLO S WARKENTIN PI
Citation: Ba. Letheby et al., PROCESSING AND CRYOPRESERVATION OF PERIPHERAL-BLOOD STEM-CELLS COLLECTED FROM NORMAL DONORS FOR ALLOGENEIC TRANSPLANTATION, Blood, 86(10), 1995, pp. 3933-3933
DETECTION OF MINIMAL RESIDUAL DISEASE IN BREAST-CANCER PATIENTS BY RT-PCR AND ICC
Authors: TRAYSTMAN MD MURPHY B SHARP JG KESSINGER A KUSZYNSKI CA PIRRUCCELLO S TARANTOLO S ZUVANICH E REED E
Citation: Md. Traystman et al., DETECTION OF MINIMAL RESIDUAL DISEASE IN BREAST-CANCER PATIENTS BY RT-PCR AND ICC, American journal of human genetics, 57(4), 1995, pp. 421-421
SUBCUTANEOUS (SC) AND INTRAVENOUS (IV) ADMINISTRATION OF RHGM-CSF FORPERIPHERAL-BLOOD STEM-CELL MOBILIZATION
Authors: KESSINGER A BISHOP M ARMITAGE JO BIERMAN PJ REED EC TARANTOLO S VOSE JM WARKENTIN PI
Citation: A. Kessinger et al., SUBCUTANEOUS (SC) AND INTRAVENOUS (IV) ADMINISTRATION OF RHGM-CSF FORPERIPHERAL-BLOOD STEM-CELL MOBILIZATION, Experimental hematology, 22(8), 1994, pp. 774-774
IN-VIVO TREATMENT OF AUTOLOGOUS BONE-MARROW WITH OLIGONUCLEOTIDE OL(1)P53 FOR ACUTE MYELOGENOUS LEUKEMIA
Authors: WHALEN VL JACKSON JD JERSHIN B BISHOP MR TARANTOLO S BAYEVER E IVERSEN P KESSINGER A SHARP JG ARMITAGE JO WARKENTIN PI
Citation: Vl. Whalen et al., IN-VIVO TREATMENT OF AUTOLOGOUS BONE-MARROW WITH OLIGONUCLEOTIDE OL(1)P53 FOR ACUTE MYELOGENOUS LEUKEMIA, Experimental hematology, 22(8), 1994, pp. 778-778
Risultati: 1-25 | 26-29